Hivid Interactions
There are 156 drugs known to interact with Hivid (zalcitabine), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 15 are major, 132 are moderate, and 9 are minor.
- View all 156 medications that may interact with Hivid
- View Hivid alcohol/food interactions (1)
- View Hivid disease interactions (3)
Most frequently checked interactions
View interaction reports for Hivid (zalcitabine) and the medicines listed below.
- acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
- Actiq (fentanyl)
- Afinitor (everolimus)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- allopurinol
- amitriptyline
- Ampyra (dalfampridine)
- Anafranil (clomipramine)
- Aptivus (tipranavir)
- Aranesp (darbepoetin alfa)
- Arixtra (fondaparinux)
- atomoxetine
- Avastin (bevacizumab)
- Azedra (iobenguane I 131)
- azithromycin
- Baraclude (entecavir)
- Benemid (probenecid)
- Blincyto (blinatumomab)
- Blocadren (timolol)
- Bosulif (bosutinib)
- brilliant green / gentian violet / proflavine hemisulfate topical
- Brineura (cerliponase alfa)
- burosumab
- cabergoline
- calcitonin
- Caprelsa (vandetanib)
- Carbaglu (carglumic acid)
- Fortovase (saquinavir)
- Videx (didanosine)
Hivid alcohol/food interactions
There is 1 alcohol/food interaction with Hivid (zalcitabine).
Hivid disease interactions
There are 3 disease interactions with Hivid (zalcitabine) which include:
Report options
QR code containing a link to this page
More about Hivid (zalcitabine)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
